Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis

Osamu Nishida, Tomoyuki Nakamura, Naohide Kuriyama, Yoshitaka Hara, Miho Yumoto, Yasuyo Shimomura, Kazuhiro Moriyama

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Citations (Scopus)

Abstract

Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) is an effective, intensive modality for sepsis treatment. Here we describe the effectiveness of SHEDD-fA, which makes the best use of three principles: dialysis, filtration and adsorption, for mediator removal in the treatment of severe sepsis. SHEDD-fA was initiated after adequate fluid resuscitation and catecholamine support had been provided. A large (2.1 m 2) polymethylmethacrylate membrane dialyzer was placed in the blood circuit. Operation conditions were as follows: blood flow rate 150 ml/min, filtration rate 1,500 ml/h (post-dilution), and dialysate flow rate 300-500 ml/min over 8-12 h daily. 55 consecutive patients with severe sepsis were studied. The following results were obtained: pressure catecholamine index significantly decreased at 3 h after initiation of septic shock, PaO 2/F IO2 significantly increased at 1 h after initiation of septic acute respiratory distress syndrome, a significant decrease in interleukin (IL)-6 level for 3 days was observed, and IL-6 was effectively adsorbed in one pass through the filter. The average sequential organ failure assessment score of patients was 10.1 and the mortality at 28 days was 16.4% (46 survived, 9 died). Because SHEDD-fA is an intensive and high-efficiency modality, removal of useful drugs or nutrients may be observed. Despite the fact that removal of useful substances cannot be ignored, we believe that an appropriate stage or timing can be identified so that we can avoid a vicious cycle and use blood purification with effective diffusion, filtration and adsorption. We demonstrate that SHEDD-fA may be an effective, intensive modality for the treatment of patients with severe sepsis and is a possible modality for cytokine modulation therapy.

Original languageEnglish
Title of host publicationHigh-Performance Membrane Dialyzers
EditorsAkira Saito, Hideki Kawanishi, Akihiro Yamashita, Michio Mineshima
Pages172-181
Number of pages10
DOIs
Publication statusPublished - 01-08-2011

Publication series

NameContributions to Nephrology
Volume173
ISSN (Print)0302-5144

Fingerprint

Sepsis
Membranes
Adsorption
Catecholamines
Interleukin-6
Organ Dysfunction Scores
Dialysis Solutions
Adult Respiratory Distress Syndrome
Polymethyl Methacrylate
Therapeutics
Septic Shock
Resuscitation
Dialysis
Cytokines
Pressure
Food
Mortality
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

Nishida, O., Nakamura, T., Kuriyama, N., Hara, Y., Yumoto, M., Shimomura, Y., & Moriyama, K. (2011). Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis. In A. Saito, H. Kawanishi, A. Yamashita, & M. Mineshima (Eds.), High-Performance Membrane Dialyzers (pp. 172-181). (Contributions to Nephrology; Vol. 173). https://doi.org/10.1159/000329057
Nishida, Osamu ; Nakamura, Tomoyuki ; Kuriyama, Naohide ; Hara, Yoshitaka ; Yumoto, Miho ; Shimomura, Yasuyo ; Moriyama, Kazuhiro. / Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis. High-Performance Membrane Dialyzers. editor / Akira Saito ; Hideki Kawanishi ; Akihiro Yamashita ; Michio Mineshima. 2011. pp. 172-181 (Contributions to Nephrology).
@inbook{c40c0a498faa43b885470f67cf1f8f86,
title = "Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis",
abstract = "Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) is an effective, intensive modality for sepsis treatment. Here we describe the effectiveness of SHEDD-fA, which makes the best use of three principles: dialysis, filtration and adsorption, for mediator removal in the treatment of severe sepsis. SHEDD-fA was initiated after adequate fluid resuscitation and catecholamine support had been provided. A large (2.1 m 2) polymethylmethacrylate membrane dialyzer was placed in the blood circuit. Operation conditions were as follows: blood flow rate 150 ml/min, filtration rate 1,500 ml/h (post-dilution), and dialysate flow rate 300-500 ml/min over 8-12 h daily. 55 consecutive patients with severe sepsis were studied. The following results were obtained: pressure catecholamine index significantly decreased at 3 h after initiation of septic shock, PaO 2/F IO2 significantly increased at 1 h after initiation of septic acute respiratory distress syndrome, a significant decrease in interleukin (IL)-6 level for 3 days was observed, and IL-6 was effectively adsorbed in one pass through the filter. The average sequential organ failure assessment score of patients was 10.1 and the mortality at 28 days was 16.4{\%} (46 survived, 9 died). Because SHEDD-fA is an intensive and high-efficiency modality, removal of useful drugs or nutrients may be observed. Despite the fact that removal of useful substances cannot be ignored, we believe that an appropriate stage or timing can be identified so that we can avoid a vicious cycle and use blood purification with effective diffusion, filtration and adsorption. We demonstrate that SHEDD-fA may be an effective, intensive modality for the treatment of patients with severe sepsis and is a possible modality for cytokine modulation therapy.",
author = "Osamu Nishida and Tomoyuki Nakamura and Naohide Kuriyama and Yoshitaka Hara and Miho Yumoto and Yasuyo Shimomura and Kazuhiro Moriyama",
year = "2011",
month = "8",
day = "1",
doi = "10.1159/000329057",
language = "English",
isbn = "9783805598125",
series = "Contributions to Nephrology",
pages = "172--181",
editor = "Akira Saito and Hideki Kawanishi and Akihiro Yamashita and Michio Mineshima",
booktitle = "High-Performance Membrane Dialyzers",

}

Nishida, O, Nakamura, T, Kuriyama, N, Hara, Y, Yumoto, M, Shimomura, Y & Moriyama, K 2011, Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis. in A Saito, H Kawanishi, A Yamashita & M Mineshima (eds), High-Performance Membrane Dialyzers. Contributions to Nephrology, vol. 173, pp. 172-181. https://doi.org/10.1159/000329057

Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis. / Nishida, Osamu; Nakamura, Tomoyuki; Kuriyama, Naohide; Hara, Yoshitaka; Yumoto, Miho; Shimomura, Yasuyo; Moriyama, Kazuhiro.

High-Performance Membrane Dialyzers. ed. / Akira Saito; Hideki Kawanishi; Akihiro Yamashita; Michio Mineshima. 2011. p. 172-181 (Contributions to Nephrology; Vol. 173).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis

AU - Nishida, Osamu

AU - Nakamura, Tomoyuki

AU - Kuriyama, Naohide

AU - Hara, Yoshitaka

AU - Yumoto, Miho

AU - Shimomura, Yasuyo

AU - Moriyama, Kazuhiro

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) is an effective, intensive modality for sepsis treatment. Here we describe the effectiveness of SHEDD-fA, which makes the best use of three principles: dialysis, filtration and adsorption, for mediator removal in the treatment of severe sepsis. SHEDD-fA was initiated after adequate fluid resuscitation and catecholamine support had been provided. A large (2.1 m 2) polymethylmethacrylate membrane dialyzer was placed in the blood circuit. Operation conditions were as follows: blood flow rate 150 ml/min, filtration rate 1,500 ml/h (post-dilution), and dialysate flow rate 300-500 ml/min over 8-12 h daily. 55 consecutive patients with severe sepsis were studied. The following results were obtained: pressure catecholamine index significantly decreased at 3 h after initiation of septic shock, PaO 2/F IO2 significantly increased at 1 h after initiation of septic acute respiratory distress syndrome, a significant decrease in interleukin (IL)-6 level for 3 days was observed, and IL-6 was effectively adsorbed in one pass through the filter. The average sequential organ failure assessment score of patients was 10.1 and the mortality at 28 days was 16.4% (46 survived, 9 died). Because SHEDD-fA is an intensive and high-efficiency modality, removal of useful drugs or nutrients may be observed. Despite the fact that removal of useful substances cannot be ignored, we believe that an appropriate stage or timing can be identified so that we can avoid a vicious cycle and use blood purification with effective diffusion, filtration and adsorption. We demonstrate that SHEDD-fA may be an effective, intensive modality for the treatment of patients with severe sepsis and is a possible modality for cytokine modulation therapy.

AB - Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) is an effective, intensive modality for sepsis treatment. Here we describe the effectiveness of SHEDD-fA, which makes the best use of three principles: dialysis, filtration and adsorption, for mediator removal in the treatment of severe sepsis. SHEDD-fA was initiated after adequate fluid resuscitation and catecholamine support had been provided. A large (2.1 m 2) polymethylmethacrylate membrane dialyzer was placed in the blood circuit. Operation conditions were as follows: blood flow rate 150 ml/min, filtration rate 1,500 ml/h (post-dilution), and dialysate flow rate 300-500 ml/min over 8-12 h daily. 55 consecutive patients with severe sepsis were studied. The following results were obtained: pressure catecholamine index significantly decreased at 3 h after initiation of septic shock, PaO 2/F IO2 significantly increased at 1 h after initiation of septic acute respiratory distress syndrome, a significant decrease in interleukin (IL)-6 level for 3 days was observed, and IL-6 was effectively adsorbed in one pass through the filter. The average sequential organ failure assessment score of patients was 10.1 and the mortality at 28 days was 16.4% (46 survived, 9 died). Because SHEDD-fA is an intensive and high-efficiency modality, removal of useful drugs or nutrients may be observed. Despite the fact that removal of useful substances cannot be ignored, we believe that an appropriate stage or timing can be identified so that we can avoid a vicious cycle and use blood purification with effective diffusion, filtration and adsorption. We demonstrate that SHEDD-fA may be an effective, intensive modality for the treatment of patients with severe sepsis and is a possible modality for cytokine modulation therapy.

UR - http://www.scopus.com/inward/record.url?scp=84958629257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958629257&partnerID=8YFLogxK

U2 - 10.1159/000329057

DO - 10.1159/000329057

M3 - Chapter

C2 - 21865790

AN - SCOPUS:84958629257

SN - 9783805598125

T3 - Contributions to Nephrology

SP - 172

EP - 181

BT - High-Performance Membrane Dialyzers

A2 - Saito, Akira

A2 - Kawanishi, Hideki

A2 - Yamashita, Akihiro

A2 - Mineshima, Michio

ER -

Nishida O, Nakamura T, Kuriyama N, Hara Y, Yumoto M, Shimomura Y et al. Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis. In Saito A, Kawanishi H, Yamashita A, Mineshima M, editors, High-Performance Membrane Dialyzers. 2011. p. 172-181. (Contributions to Nephrology). https://doi.org/10.1159/000329057